105: An Interview With Selene Capodarca, Global Study Coordinator for HD-Enroll

Rare Care Podcast

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Selene Capodarca. This Italian expert in pharmaceutical chemistry and technology, is the global study director for Enroll-HD, with 30,000 patients the world's largest observational study in Huntington disease.